Abstract-The chronic hypoxia of high-altitude (HA) residence reduces uterine artery blood flow during pregnancy, likely contributing to an increased frequency of preeclampsia and intrauterine growth restriction. We hypothesized that this lesser pregnancy blood flow rise was due, in part, to reduced vasodilation of myometrial arteries (MAs). Here, we assessed MA vasoreactivity in healthy residents of high (2902±39 m) or low altitude (LA; 1669±10 m). MA contractile responses to potassium chloride, phenylephrine, or the thromboxane A2 agonist U46619 did not differ between LA and HA women. Acetylcholine vasodilated phenylephrine or U466119 preconstricted MAs at LA, yet had no effect on HA MAs. In contrast, another vasodilator, bradykinin, relaxed MAs from both altitudes similarly. At LA, the NO synthase inhibitor L-N G -nitroarginine methyl ester decreased both acetylcholine and bradykinin vasodilation by 56% and 33%, respectively. L-N G -nitroarginine methyl ester plus the COX (cyclooxygenase) inhibitor indomethacin had similar effects on acetylcholine and bradykinin vasodilation (68% and 42% reduction, respectively) as did removing the endothelium (78% and 50% decrease, respectively), suggesting a predominantly NO-dependent vasodilation at LA. However, at HA, L-N G -nitroarginine methyl ester did not change bradykinin vasodilation, whereas indomethacin or endothelium removal decreased it by 28% and 72%, respectively, indicating impaired NO signaling at HA. Suggesting that the impairment was downstream of eNOS (endothelial NO synthase), HA attenuated the vasodilation elicited by the NO donor sodium nitroprusside. We concluded that reduced NO-dependent MA vasodilation likely contributes to diminished uteroplacental perfusion in HA pregnancies.
T he chronic hypoxia of high-altitude (HA) residence (>2500 m) raises the incidence of preeclampsia and intrauterine growth restriction (IUGR) 3-fold. [1] [2] [3] Contributing to these pregnancy disorders is a lesser rise in uterine artery blood flow across gestation, suggesting that chronic hypoxia impairs uterine vascular adaptation to pregnancy. [4] [5] [6] [7] [8] Although hypoxia is a consequence of uterine vascular impairment, the increased incidence of these pregnancy disorders at HA suggests that hypoxia contributes to their pathogenesis as well.
Considerable experimental animal data indicate that chronic hypoxia interferes with the normal uterine vascular responses to pregnancy. The normal growth of the main uterine artery is impaired in chronically hypoxic pregnant guinea pigs due, in part, to less pregnancy-associated rise in DNA synthesis in all layers of the uterine artery wall. 9 Fourthgeneration uterine vessels from sheep chronically exposed to HA have increased myogenic tone, less potassium channelinduced vasodilation, [10] [11] [12] [13] and augmented oxidative stress.
14 Pregnant rats and guinea pigs exposed to hypoxia during pregnancy also have diminished vasodilator responses 15, 16 and less NO-dependent vasodilation. 17 Impaired vasodilation of myometrial arteries (MAs) and incomplete remodeling of uterine spiral arteries are likely the primary causes of the reduced uteroplacental perfusion characterizing IUGR and preeclampsia. [4] [5] [6] 18 MAs are key determinants of uterine vascular resistance and uteroplacental blood flow during human pregnancy given the pronounced increases in the diameters of both the upstream and downstream vessels. 19 Demonstrating the importance of MA vascular responses, MA from preeclamptic pregnancies show reduced vasodilator responses to flow and vasodilating agents compared with those from uncomplicated pregnancies. [4] [5] [6] 20 However, whether chronic hypoxia affects human MA vasoreactivity during normal pregnancy is unknown.
Here, we tested the hypothesis that residence at HA reduces human MA vasodilation compared with low altitude (LA; <1700 m) in uncomplicated pregnancies. In phenylephrine (PE) or U46619-preconstricted vessels, we observed that the vasodilatory responses to acetylcholine (ACh) were blunted in MA from HA versus LA. Although bradykinin (BK)-dependent vasodilation was similar at both altitudes, the NO contribution differed insofar as vasodilation was largely NO dependent at LA but NO independent at HA. These observations suggest that impaired NO-dependent vasodilation of the MA may be a key contributor to reduced uterine artery blood flow and fetal growth in HA pregnancies.
Methods
All data supporting the findings of this study will be available on request from the authors. For detailed Methods, see the online-only Data Supplement.
Study Subjects and Tissue Samples
Subjects were classified into 2 groups: those living above 2500 m (HA, n=20 subjects) and those living below 1700 m (LA, n=40 subjects). Subject inclusion criteria were maternal age from 18 to 45 years, prepregnant body mass index <30 kg/m 2 ; we excluded subjects with known risk factors for IUGR (ie, diabetes mellitus, chronic hypertension, and smoking) or diagnoses during the current pregnancy of IUGR, preeclampsia, or the presence of fetal congenital anomalies. Before sample collection, all subjects signed written consent forms approved by the University of Colorado Multiple Institutional Review Board or the Catholic Health Initiative Institute for Research and Innovation Institutional Review Board (1310). Myometrial biopsies were processed as detailed in the online-only Data Supplement.
Myometrial Vascularization Measurements
Myometrial samples (0.5 cm 3 sections) were fixed in 4% paraformaldehyde (Affymetrix, Cleveland, OH), stained with anti-CD31 (platelet and endothelial cell adhesion molecule 1) and α-SMA (α-smooth muscle actin) antibodies. Number and size of vessels (as identified by CD31 staining) were analyzed using STEPanizer and Image J software, respectively.
MA Vasoreactivity
MAs were cleaned from connective tissue in ice-cold phosphate saline buffer (PBS; Thermo Fisher Scientific, Waltham, MA) and mounted in a small-vessel wire myograph (Multi Wire Myograph System 620M; DMT-USA, Ann Arbor, MI) with 2 wires (40-µm diameter) threaded through the vessel lumen and connected to either a tension transducer or micrometer. The vessels were normalized to an internal diameter of 0.9 of L 13.3kPa in a chamber containing oxygenated (95% O 2 /5% CO 2 ) and warmed (37°C) Krebs buffer (118 mmol/L NaCl, 4.7 mmol/L KCl, 2.5 mmol/L CaCl 2 , 1.2 mmol/L MgSO 4 , 1.2 mmol/L KH 2 PO 4 , 25 mmol/L NaHCO 3 , and 11 mmol/L D-glucose). After at least 45 minutes of equilibration, MAs were constricted with 60 mmol/L KCl (Sigma-Aldrich, St. Louis, MO) to establish viability; vessels failing to constrict at least 1 mN (estimated as an appropriate signal-to-noise ratio for tension measurement) were excluded from further study. Vessels were preconstricted with either 10 µmol/L PE (Sigma-Aldrich; 78.8±3.7% of maximal PE response at LA and 87.8±3.5% at HA) or 1 µmol/L U46619 (Cayman Chemical, Ann Arbor, MI)-a thromboxane A2 agonist (99.9±0.01% of maximal U46619 response at LA and 98.9±0.7% at HA), and the vasodilator response to either ACh or bradykinin (ACh, 0.1 nmol/L to 100 µmol/L; BK, 0.1 nmol/L to 1 µmol/L; Thermo Fisher Scientific) was evaluated, with each dosage being applied for 3 to 5 minutes before achieving the next concentration.
To assess the contributions of endothelial factors, vessels were incubated for 20 minutes with either the NO synthase inhibitor L-N G -nitroarginine methyl ester (L-NAME, 10 µmol/L; BioVision, Inc, Milpitas, CA) or L-NAME (10 µmol/L) plus the COX (cyclooxygenase) inhibitor indomethacin (Indo, 10 µmol/L; Sigma-Aldrich) before PE constriction and the application of ACh or BK. In a subset of MA, the endothelial cell layer was mechanically disrupted by rolling a hair through the vessel lumen; loss of endothelial function was judged as <30% relaxation to 10 µmol/L ACh or 10 nmol/L BK. To assess changes in NO signaling, HA or LA MAs were preconstricted with 10 µmol/L PE and then vasodilated with the NO donor sodium nitroprusside (SNP; 0.1 nmol/L to 100 µmol/L). ACh, BK, and SNP relaxation are shown as percentage of PE or U46619 contraction. Area under the curve was calculated using Graph Pad 7 software (San Diego, CA).
Western Blot Analysis
Myometrial lysates were tested for total eNOS (endothelial NO synthase), Ser-1177 phosphorylated eNOS, or CD31.
Statistical Analyses
Sample sizes are shown as the number of subjects followed by the total number of vessels. In vascular function experiments, vessels from the same subject under the same conditions were averaged; in average 3.1±0.2 (ranging from 1 to 7) vessels per subject were used. The effects of drug treatment or altitude were determined using 2-way ANOVA followed by Sidak multiple comparisons or by nonparametric MannWhitney U test (Graph Pad 7 software) as needed. Demographic, immunohistochemistry, and Western blot data were analyzed by nonparametric Mann-Whitney U test or χ 2 analysis (Graph Pad 7 software) as needed. A P <0.05 was considered significant.
Results

Subject Characteristics and Myometrial Vascular Parameters
Maternal age, height, pregravid body mass index, parity, and ethnicity, as well as infant length at birth and sex were similar in the LA and HA pregnancies (Table) . However, the birth weight of babies born to women living at HA was 11% lower than those born at LA (P<0.001; Table) . In addition, ponderal index and, marginally, head circumference but not length were also reduced by altitude (P<0.001 and <0.05, respectively) consistent with lower birth weights being due to fetal growth restriction rather than constitutional factors (Table) . Gestational age was slightly (but clinically insignificantly) shorter in HA versus LA pregnancies (P<0.05; Table) . The numbers and sizes of myometrial blood vessels were similar in women living at LA and HA as demonstrated by the lack of differences in either the vascular volume fraction or average blood vessel perimeter ( Figure 1 ).
Vasoconstrictor Responses to KCl, PE, and U46619
MAs from LA and HA vasoconstricted similarly to increasing concentrations of KCl as shown by the absence of differences in maximal force or half-maximal effective concentration (EC 50 ) whether the latter was expressed as absolute force or normalized to K max ( Figure S1 in the online-only Data Supplement; Table S1 ). Likewise, there were no altitudinal differences in the MA vasoconstrictor responses to PE or U46619 as measured by the maximal force or normalized to K max ( Figure S1 ; Table S1 ).
ACh Vasodilator Response in MA
In LA vessels, PE-preconstricted MA vasodilated in response to ACh in a concentration-dependent manner, but HA MA had a blunted vasodilator response to ACh (P<0.05; Figure 2A ). Using a different vasoconstrictor, U46619, to preconstrict MA, ACh also vasodilated LA MA to a greater extent than in HA MA (P<0.05; Figure 2B ).
To evaluate the contribution of endothelial signaling, ACh-dependent vasodilation was compared in MA with and without prior incubation with L-NAME, L-NAME plus Indo, or endothelium removal in PE-preconstricted vessels. Preincubation with L-NAME diminished ACh vasodilation in LA MA (P<0.05; Figure 2C and 2E) as did removal of the endothelial layer (P<0.05; Figure 2C and 2E). Incubation of LA MA with L-NAME plus Indo reduced ACh vasodilation to a similar extent compared with that observed with L-NAME alone (P<0.05; Figure 2C and 2E). At HA, there was no effect of either incubation with L-NAME alone, L-NAME plus Indo, or endothelial removal ( Figure 2D and 2F) on ACh vasodilation.
To consider the possibility that ACh may be exerting a vasoconstrictor effect that contributed to the lack of vasodilation observed at HA, we tested the effect of ACh without preconstricting the MA. ACh had no effect on HA MA whether administered alone, after incubation with L-NAME or L-NAME plus Indo, or in endothelium-denuded vessels ( Figure S2 ).
BK Vasodilator Response in MA
To determine whether the blunted vasodilator responses observed in HA MA were confined to ACh, we tested another vasodilator, BK. PE-preconstricted MA from both LA and HA vasodilated in response to BK ( Figure 3A ). BK-dependent vasodilation was also observed when MAs were preconstricted with U46619 at both LA and HA ( Figure 3B ).
At LA, the MA vasodilator response to BK was partially blunted by preincubation with L-NAME, L-NAME plus Indo, or by removing the endothelium (P<0.05; Figure 3C and 3E), with the effects of L-NAME and L-NAME plus Indo being indistinguishable ( Figure 3C and 3E) . Interestingly, although endothelial removal reduced the vasodilator response to BK at HA (P<0.05; Figure 3D and 3F), there was less dependence on NO-dependent vasodilation as indicated by the lack of an effect of L-NAME ( Figure 3D and 3F) and only partial attenuation of BK vasodilation achieved by L-NAME plus Indo (P<0.05; Figure 3D ).
NO Signaling
To address whether a reduction in NO signaling could explain the lack of effect of L-NAME on BK-dependent vasodilation of HA MA, we analyzed the activation of eNOS in myometrial samples from LA and HA women as measured by phosphorylation of residue Ser-1177. Total amounts of eNOS and Ser-1177 phosphorylated eNOS protein were similar in myometrial samples from HA and LA women ( Figure 4A ).
Because basal eNOS activity did not change between LA and HA, we assessed the role of downstream NO signaling pathways on ACh vasodilation by examining the effect of the NO donor SNP in the MA from LA and HA women. Even though SNP vasodilated the vessels from both altitudes, the response to SNP in the HA MA was attenuated compared with that seen in the LA MA (P<0.05; Figure 4B and 4C) indicating a likely impairment in downstream, sGC (soluble guanylate cyclase)/PKG (protein kinase G) pathways.
Discussion
Given the important role of the MA in the regulation of uterine vascular resistance 19 and prior observations that uterine blood flow is reduced during HA compared with LA pregnancy, we tested whether MA vasodilator function is impaired under conditions of HA. Our study results showed that residence at HA reduced ACh-dependent vasodilation in MA from healthy pregnant women because of impaired NO signaling. The lack of ACh vasodilation was not the result of altitudinal differences in vasoconstrictor responses because the responses to several agonists (KCl, PE, U46619) were identical, and, therefore, the effect of HA was specific to MA vasodilation. There were also no differences between altitudes in the number or size of the MA, possibly because of the fact that the myometrial samples used in this study were not obtained from the site of placentation and indicating that the effect of altitude was specific to vasodilator function of the MA themselves. The lack of MA vasodilation appeared to be the result of impaired NO signaling given that L-NAME had no effect on BK vasodilation in HA MA, whereas MA vasodilation was largely dependent on increased NO production at LA. Thus, although HA MA vasodilated in response to BK, such vasodilation was less dependent on NO at HA than at LA. Furthermore, the responses to the NO donor SNP were attenuated in HA compared with LA MA, suggesting that the reduced vasodilator response to ACh in HA MA was because of impaired downstream NO signaling.
Our results were consistent with several lines of evidence indicating that hypoxia is not only a consequence of impaired vasodilation but also contributes to its pathogenesis. We and others have reported the pregnancy complications of preeclampsia and IUGR to be increased in populations living at HA where ambient Po 2 is 20% to 50% lower than at sea level depending on the elevation. 1, 3, 21 Although the incidence of preeclampsia is increased at HA, its week of onset is not different from LA in Colorado. 3 Furthermore, severe preeclampsia at HA accounts for a greater proportion (21%) of intrauterine deaths at HA than LA in Bolivia, 22 but whether the incidence of severe preeclampsia is increased at HA is unknown. Moreover, IUGR and symptoms of preeclampsia can be replicated in animal models of pregnancy exposed to chronic hypoxia. 16, 23, 24 Our findings were also consistent with previous studies on the effects of chronic hypoxia exposure in uterine arteries from pregnant experimental animals. For instance, although chronic hypoxia did not change uterine artery vasoconstrictor response to PE 25 or vasodilator responses to ACh or BK in pregnant guinea pigs, there was less NO-dependent vasodilation at HA versus LA. 17 In rats exposed to hypoxia, NO-dependent cholinergic uterine artery vasodilation was also diminished without affecting vasoconstrictor responses. 16 Similarly, chronic hypoxia elevated myogenic tone in ovine uterine arteries by inhibiting large-conductance Ca 2+ -activated K + (BK Ca ) channel activity via increased oxidative stress, upregulation of PKC (protein kinase C), and reduction of BK Ca β1 subunit expression. 10, 12, 26 Because in human umbilical vessels, ACh induces vasoconstriction by a mechanism involving increased PKC activity and reduction of smooth muscle BK Ca channels, 27 it is possible that the nitroarginine methyl ester (L-NAME; squares, n=5 subjects, 9 vessels at LA, and 5 subjects, 5 vessels at HA) or 10 µmol/L L-NAME+10 µmol/L indomethacin (Indo; diamonds, n=4 subjects, 7 vessels at LA, and 5 subjects, 5 vessels at HA), or their endothelium was removed (endothelium, triangles, n=4 subjects, 5 vessels at LA, and 6 subjects, 9 vessels at HA). E and F, Area under the curve (AUC) analysis of curves in C and D, respectively. Symbols in A-D are mean values, bars are SEM; symbols in E and F are averaged vessels per subject, lines are medians. Different italicized letters represent statistical differences with a P <0.05.
blunted vasodilator response to ACh in HA MA is because of reduced BK Ca activation.
Human MAs from pregnancies complicated by IUGR and preeclampsia compared with normal pregnancies have decreased MA lumenal diameters 28 ; blunted vasodilator responses to ACh, 20 BK, 6, 18, 29 and shear stress 5 ; and increased U46619-induced oscillations in vascular tone. 30 Our study aligns with these observations and indicates that hypoxia due to residence at HA, without the other pathophysiological characteristics of preeclampsia or IUGR, impairs the vasodilator response to ACh in otherwise healthy women. Moreover, because MAs were not obtained from the site of placentation, the changes in MA vasodilator response observed were not a function of trophoblast-induced spiral arteriolar or MA remodeling. 31 Because the hypoxia present in preeclamptic or IUGR pregnancies is likely local in nature, whereas global hypoxia is present under the circumstances of HA pregnancy, future studies are warranted to determine whether IUGR pregnancies at HA have further impaired vasodilation of MA and whether their mechanisms are similar to those from IUGR pregnancies at LA.
Given the lesser dependence on NO-induced vasodilation seen in the HA versus the LA MA in our study, we asked whether there was less expression of eNOS protein.
Because eNOS expression is restricted to endothelial cells in myometrial tissue, 32 we were able to measure its expression and activation by phosphorylation of Ser-1177 in whole in myometrial tissue. By using CD31 rather than total myometrial protein, we were able to normalize the amount of eNOS protein expression and activation relative to the total amount of protein present in vascular tissue, thus overcoming the limitation imposed by the small amount of tissue available from MA alone. Further, because there might be more vessels in the particular section of myometrial tissue used, the use of CD31 effectively controlled for the number of vessels present. Although we found no differences in basal levels of total eNOS or phosphorylated eNOS in LA versus HA MA, we cannot discard the possibility that differences could exist under conditions of ACh, BK, or other stimulation. We did not find differences between the 2 altitudes in eNOS expression or phosphorylation. This contrasts to what has been reported in the fourth-generation uterine arteries from chronically hypoxic ovine pregnancies where upregulation of eNOS expression and increased Ca 2+ -dependent NO production has been observed. 33 However, a reduction in birth weight was not seen in such studies, 34 suggesting that upregulation of eNOS in the uterine vascular bed may have been a mechanism for protecting against hypoxia-associated IUGR. Alternatively, such differences in study results could be because of variation among species or vascular beds in the effects of hypoxia. nitroarginine methyl ester (L-NAME; squares, n=7 subjects, 15 vessels at LA, and 5 subjects, 10 vessels at HA) or 10 µmol/L L-NAME+10 µmol/L indomethacin (Indo; diamonds, n=5 subjects, 12 vessels at LA, and 5 subjects, 6 vessels at HA), or their endothelium was removed (endothelium, triangles, n=6 subjects, 9 vessels at LA, and 5 subjects, 8 vessels at HA). E and F, Area under the curve (AUC) analysis of curves in C and D, respectively. Symbols in A-D are mean values, bars are SEM; symbols in E and F are averaged vessels per subject, lines are medians. Different italicized letters represent statistical differences with a P <0.05.
Rather, our studies indicated that the mechanisms by which chronic hypoxia decreased MA vasodilator response and NO dependence were downstream of NO production. Specifically, whereas the NO donor SNP prompted MA vasodilation, the maximal vasodilation achieved was reduced in MA from HA compared with LA. However, because the expression and activation of eNOS in myometrial vessels was measured under unstimulated conditions and the reduced maximal vasodilation to SNP seen at HA was not as marked as the decrease in ACh response, we cannot exclude the possibility that other mechanisms may also be contributing to the lack of ACh vasodilation at HA. Such mechanisms may include (1) attenuation of muscarinic ACh receptor expression or function, (2) reduced Ca 2+ -dependent eNOS activation as has been shown in pulmonary arteries from chronically hypoxic sheep, 35 and (3) the possibility that differences in eNOS activity might be present under stimulated conditions. Therefore, future studies assessing expression and function of muscarinic ACh receptors, Ca 2+ -dependent eNOS activation, and NO production under stimulated conditions are necessary to elucidate the mechanisms by which HA impairs ACh vasodilation.
As summarized in Figure 5 , we propose that while both ACh and BK vasodilate MA in an endothelial-and NO-dependent manner at LA, the chronic hypoxia of HA alters endothelial NO-dependent pathways to reduce ACh-elicited vasodilation of MA. The vasodilator response to BK is unaffected because BK can act through NO and endothelium-independent mechanisms by, for example, increasing production of vasodilator prostaglandins or EDHF (endothelial-derived hyperpolarization factor); however, the contribution of NO to BK vasodilation is still impaired in HA MA. Further, we propose that the mechanism by which NO signaling is disrupted in HA MA is not because of the lack of basal eNOS activation because its phosphorylation at Ser-1177 was unchanged but by the reduction in downstream effectors, such as sGC/PKG pathways, as evidenced by the attenuated relaxation in response to the exogenous NO donor SNP.
In summary, we concluded that our data indicated that chronic hypoxia reduced NO-dependent vasodilation in MA, which probably, in turn, contributes to raising uterine vascular resistance, lowering uterine artery blood flow and thereby hypoxia-related fetal growth restriction.
Perspectives
Our data demonstrate that HA diminished cholinergic-dependent vasodilation of MA without changing the MA vasoconstrictor response or myometrial vascularity and was due, in part, to a reduction in NO signaling and was accompanied by a decrease in birth weight. These studies contribute to our understanding of the effects of chronic hypoxia on uterine vascular responses to pregnancy in a setting where fetal growth restriction occurs. Because hypoxia characterizes IUGR or preeclampsia at any altitude, understanding the mechanisms by which hypoxia impairs myometrial vascular function during pregnancy is essential for identifying therapeutic targets for improving the treatments for women and their infants experiencing such hypoxia-related pregnancy complications. ACh and BK activate eNOS (endothelial NO synthase) by phosphorylation of Ser-1177 to produce NO, which diffuses to the smooth muscle cells (SMCs) where it activates sGC (soluble guanylate cyclase) to increase cyclic GMP (cGMP) levels, and in turn, promote PKG (protein kinase G) activity, relaxation of the SMC, and vasodilation of the MA. BK also acts through an unknown, largely endothelium-independent mechanism to induce relaxation of SMC. At high altitude, even though basal Ser-1177 phosphorylation of eNOS remains unchanged, decreased vasodilator response to the NO donor sodium nitroprusside suggests that the activation of the downstream NO pathway (ie, sGC-cGMP-PKG) is reduced and thereby impairs ACh vasodilation of MA. Conversely, BK vasodilates MA at high altitude partially by activating COX (cyclooxygenase)-dependent production of prostaglandins (PGs) but also by 2 other putative mechanisms: an endotheliumdependent (likely EDHF [endothelial-derived hyperpolarizing factor]) and an unknown, largely endothelium-independent mechanism. mAChR, muscarinic ACh receptor; B 1/2 , bradykinin receptor B 1 or B 2 ; L-arg, L-arginine, AA, arachidonic acid.
